Mental Health

Rocket Doctor and Engagewell IPA Win New York Health Foundation Grant to Expand ‘Healthcare in Housing’ for Residents in Inner-City NY

Partnership Lets Patients in Supportive Housing Access Comprehensive Virtual Primary Care and Mental Health Services, Powered by Device Kiosks and...

Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / November 29, 2023 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the clinical-stage pharmaceutical company developing psilocybin therapy...

Alladapt Immunotherapeutics Receives FDA Fast Track Designation for ADP101 for the Treatment of Mono- and Multi-Food Allergies

– Fast Track Designation accelerates ADP101's development path for the treatment of mono- and multi-food allergy – – Phase 1/2...

error: Content is protected !!